Sangamo's landmark genome editing trial gets mixed reception.
Nature biotechnology, 36(10): 907-908 PMID 30307929 DOI 10.1038/nbt1018-907
Abstract
This article has no abstract in PubMed.
Your browser does not allow saving data (e.g. private mode): bookmarks will be lost when the tab closes.